Free Trial

Onconetix (ONCO) Short Interest Ratio & Short Volume

$0.14
-0.01 (-6.61%)
(As of 05/23/2024 ET)

Onconetix Short Interest Data

Current Short Interest
56,000 shares
Previous Short Interest
476,100 shares
Change Vs. Previous Month
-88.24%
Dollar Volume Sold Short
$6,557.60
Short Interest Ratio
0.1 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
22,328,000 shares
Float Size
17,780,000 shares
Short Percent of Float
0.31%
Today's Trading Volume
636,417 shares
Average Trading Volume
2,678,043 shares
Today's Volume Vs. Average
24%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Onconetix ?

Sign up to receive the latest short interest report for Onconetix and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ONCO Short Interest Over Time

ONCO Days to Cover Over Time

ONCO Percentage of Float Shorted Over Time

Onconetix Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202456,000 shares $6,557.60 -88.2%0.3%0.1 $0.12
4/15/2024476,100 shares $67,177.71 -9.7%2.9%0.1 $0.14
3/31/2024527,200 shares $81,188.80 -17.1%3.2%0.1 $0.15
3/15/2024635,600 shares $101,060.40 -9.0%3.8%0.2 $0.16
2/29/2024698,200 shares $119,392.20 -48.3%4.2%0.2 $0.17
2/15/20241,350,000 shares $227,340.00 +52.5%8.2%0.4 $0.17
1/31/2024885,200 shares $169,161.72 No Change7.1%0.2 $0.19

ONCO Short Interest - Frequently Asked Questions

What is Onconetix's current short interest?

Short interest is the volume of Onconetix shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 56,000 shares of ONCO short. 0.31% of Onconetix's shares are currently sold short. Learn More on Onconetix's current short interest.

What is a good short interest percentage for Onconetix?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.31% of Onconetix's floating shares are currently sold short.

Is Onconetix's short interest increasing or decreasing?

Onconetix saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 56,000 shares, a decrease of 88.2% from the previous total of 476,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Onconetix's float size?

Onconetix currently has issued a total of 22,328,000 shares. Some of Onconetix's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Onconetix currently has a public float of 17,780,000 shares.

How does Onconetix's short interest compare to its competitors?

0.31% of Onconetix's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Onconetix: 60 Degrees Pharmaceuticals, Inc. (1.31%), Altamira Therapeutics Ltd. (6.57%), Notable Labs, Ltd. (0.08%), Agile Therapeutics, Inc. (12.68%), Sonoma Pharmaceuticals, Inc. (0.30%), Dermata Therapeutics, Inc. (1.28%), Salarius Pharmaceuticals, Inc. (1.65%), Clearmind Medicine Inc. (5.51%), Avenue Therapeutics, Inc. (3.26%), Mustang Bio, Inc. (0.91%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Onconetix stock?

Short selling ONCO is an investing strategy that aims to generate trading profit from Onconetix as its price is falling. ONCO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Onconetix?

A short squeeze for Onconetix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONCO, which in turn drives the price of the stock up even further.

How often is Onconetix's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONCO, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ONCO) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners